Identification of an allosteric pocket on human Hsp70 reveals a mode of inhibition of this therapeutically important protein

54Citations
Citations of this article
76Readers
Mendeley users who have this article in their library.

Abstract

Summary Hsp70s are important cancer chaperones that act upstream of Hsp90 and exhibit independent anti-apoptotic activities. To develop chemical tools for the study of human Hsp70, we developed a homology model that unveils a previously unknown allosteric site located in the nucleotide binding domain of Hsp70. Combining structure-based design and phenotypic testing, we discovered a previously unknown inhibitor of this site, YK5. In cancer cells, this compound is a potent and selective binder of the cytosolic but not the organellar human Hsp70s and has biological activity partly by interfering with the formation of active oncogenic Hsp70/Hsp90/client protein complexes. YK5 is a small molecule inhibitor rationally designed to interact with an allosteric pocket of Hsp70 and represents a previously unknown chemical tool to investigate cellular mechanisms associated with Hsp70. © 2013 Elsevier Ltd.

Cite

CITATION STYLE

APA

Rodina, A., Patel, P. D., Kang, Y., Patel, Y., Baaklini, I., Wong, M. J. H., … Chiosis, G. (2013). Identification of an allosteric pocket on human Hsp70 reveals a mode of inhibition of this therapeutically important protein. Chemistry and Biology, 20(12), 1469–1480. https://doi.org/10.1016/j.chembiol.2013.10.008

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free